Literature DB >> 12653968

Alpha2A and alpha2C-adrenoceptor regulation in the brain: alpha2A changes persist after chronic stress.

G Flügge1, M van Kampen, H Meyer, E Fuchs.   

Abstract

Stress-induced activation of the central nervous noradrenergic system has been suspected to induce depressive disorders. As episodes of depression often occur some time after a stress experience we investigated whether stress-induced changes in the alpha2-adrenoceptor (alpha2-AR) system persist throughout a post-stress recovery period. Brains of male tree shrews were analysed after 44 days of chronic psychosocial stress and after a subsequent 10-day recovery period. Expression of RNA for alpha2A and alpha2C-adrenoceptors was quantified by in situ hybridization, and receptor binding was determined by in vitro receptor autoradiography. Activities of the sympathetic nervous system and of the hypothalamo-pituitary-adrenal axis were increased during chronic stress but normalized during recovery. Alpha2A-AR RNA in the glutamatergic neurons of the lateral reticular nucleus was elevated significantly after stress and after recovery (by 29% and 17%). In the dorsal motor nucleus of the vagus, subtype A expression was enhanced after recovery (by 33%). In the locus coeruleus, subtype A autoreceptor expression was not changed significantly. Subtype C expression in the caudate nucleus and putamen was elevated by stress (by 5 and 4%, respectively) but normalized during recovery. Quantification of 3H-RX821002 binding revealed receptor upregulation during stress and/or recovery. Our data therefore show: (i) that chronic psychosocial stress differentially regulates expression of alpha2-adrenoceptor subtypes A and C; (ii) that subtype A heteroreceptor expression is persistently upregulated whereas (iii), subtype C upregulation is only transient. The present findings coincide with post mortem studies in depressed patients revealing upregulation of alpha2A-ARs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653968     DOI: 10.1046/j.1460-9568.2003.02510.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  22 in total

1.  The alpha-2B adrenoceptor in the paraventricular thalamic nucleus is persistently upregulated by chronic psychosocial stress.

Authors:  U Heilbronner; M van Kampen; G Flügge
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

2.  Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine.

Authors:  Anna Krzyczmonik; Thomas Keller; Francisco R López-Picón; Sarita Forsback; Anna K Kirjavainen; Jatta S Takkinen; Aleksandra Wasilewska; Mika Scheinin; Merja Haaparanta-Solin; Franciszek Sączewski; Olof Solin
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

Review 3.  Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications.

Authors:  Antonio R Artalejo; Luis Alcides Olivos-Oré
Journal:  Pflugers Arch       Date:  2017-08-23       Impact factor: 3.657

4.  Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice.

Authors:  E Moura; J Afonso; L Hein; M A Vieira-Coelho
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

5.  Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

Authors:  Sudhirkumar U Yanpallewar; Kimberly Fernandes; Swananda V Marathe; Krishna C Vadodaria; Dhanisha Jhaveri; Karen Rommelfanger; Uma Ladiwala; Shanker Jha; Verena Muthig; Lutz Hein; Perry Bartlett; David Weinshenker; Vidita A Vaidya
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 6.  Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake.

Authors:  Klaus A Miczek; Jasmine J Yap; Herbert E Covington
Journal:  Pharmacol Ther       Date:  2008-08-15       Impact factor: 12.310

7.  Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats.

Authors:  Abbey L Reed; Jeffrey C Anderson; David B Bylund; Frederick Petty; Hesham El Refaey; H Kevin Happe
Journal:  Psychopharmacology (Berl)       Date:  2009-04-22       Impact factor: 4.530

8.  Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stress.

Authors:  Janel M Boyce-Rustay; Benjamin Palachick; Kathryn Hefner; Yi-Chyan Chen; Rose-Marie Karlsson; Rachel A Millstein; Judith Harvey-White; Andrew Holmes
Journal:  Neuropharmacology       Date:  2008-06-26       Impact factor: 5.250

9.  Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome.

Authors:  Steven Berman; Brandall Suyenobu; Bruce D Naliboff; Joshua Bueller; Jean Stains; Heng Wong; Mark Mandelkern; Leah Fitzgerald; Gordon Ohning; Arpana Gupta; Jennifer S Labus; Kirsten Tillisch; Emeran A Mayer
Journal:  Neuroimage       Date:  2012-08-21       Impact factor: 6.556

Review 10.  Towards a systems view of IBS.

Authors:  Emeran A Mayer; Jennifer S Labus; Kirsten Tillisch; Steven W Cole; Pierre Baldi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-25       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.